首页> 外文期刊>Blood coagulation & fibrinolysis: an international journal in haemostasis and thrombosis >Recurrent severe bleeding from gastrointestinal angiodysplasia in a patient with von Willebrand's disease, controlled with recombinant factor VIIa.
【24h】

Recurrent severe bleeding from gastrointestinal angiodysplasia in a patient with von Willebrand's disease, controlled with recombinant factor VIIa.

机译:由重组因子VIIa控制的von Willebrand病患者因胃肠道血管增生反复发作的严重出血。

获取原文
获取原文并翻译 | 示例
           

摘要

A patient with von Willebrand's disease had recurrent gastrointestinal bleeding from angiodysplasia, with inadequate response to von Willebrand factor substitution, medical and endoscopic treatment, and resection of affected bowel. Frequent blood transfusions were required. She started home treatment with recombinant activated factor VII (rFVIIa) at the onset of bleeding, in addition to her standard therapy. From then on, bleeds could be controlled rapidly and no more blood transfusions were needed. We conclude that rFVIIa is effective in this case of angiodysplasia and might be a therapeutic option in similar patients.
机译:一位患有von Willebrand病的患者因血管增生而反复出现胃肠道出血,对von Willebrand因子替代,药物和内镜治疗以及受累肠切除术的反应不足。需要频繁输血。除了标准疗法外,她还在出血开始时就开始用重组活化因子VII(rFVIIa)进行家庭治疗。从那时起,可以迅速控制出血,并且不再需要输血。我们得出结论,rFVIIa在这种血管增生的情况下是有效的,并且可能是类似患者的治疗选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号